Inclusion compound of lankacidin-group antibiotic and use thereof
Patent 4497803 Issued on February 5, 1985. Estimated Expiration Date: 
April 6, 2003. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
April 6, 2003. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 2959580 3869443 Nitroglycerine inclusion compounds with cyclodextrin and composition containing same Inclusion complex of cyclodextrin and indomethacin and a process for the preparation thereof, method of use and pharmaceutical composition Inclusion compound of p-hexadecylamino benzoic acid in cyclodextrin and method of use Patent #: 4407795 InventorsAssigneeApplicationNo. 06/482553 filed on 04/06/1983US Classes:514/450, The hetero ring has at least seven members514/546, ZC(=O)OY, wherein Z is an acyclic radical bonded to the C=O by a carbon and Y is an organic radical bonded to the oxygen by a carbon536/103, Dextrin or derivative536/7.1Oxygen containing hetero ring having 12-19 members (e.g., methymycin, carbomycin, spiramycin, etc.)ExaminersPrimary: Brown, Johnnie R.Assistant: Peselev, Elli Attorney, Agent or FirmInternational ClassesA61K 47/48 (20060101)C07D 493/00 (20060101) C07D 493/08 (20060101) C08B 37/00 (20060101) Foreign Application Priority Data1982-04-12 JPAbstractInclusion compound of lankacidin-group antibiotic with cyclodextrin, having enhanced water-solubility and stability and a veterinary composition containing the same, which is useful for curing swine dysentery. The compound is prepared by adding lankacidin-group antibiotic to an aqueous cyclodextrin solution and stirring.Other References
|
| ||||||||||||||
